(09:35) Sponsors: David & Helix Sleep (11:56) Eye Contact in Babies, Fever
2.0 0.4 V s), (2) GLP-1 receptor expression was increased in renal pelvis, (3) response of increase in RSNA to intravenous infusion of GLP-1 was enhanced (132 30% vs
Obesity is a chronic disease influenced by metabolic pathways, hormonal signals, genetics, and long-standing behavioral patterns
These findings suggest that the gut microbiota may promote the onset and progression of EDC through the propagation of inflammatory signals that activate both peripheral and central immune responses
Early Discoveries, With More to Come So far, GLP-1s, first approved 20 years ago for type 2 diabetes and later obesity, have shown potential in treating a surprisingly wide range of conditions, such as heart disease, Parkinsons, Alzheimers, sleep apnea, and liver disease